Niclas Källbom Karlsson, general manager of GSK Sweden, reflects on his first five years of heading the local affiliate, in which the company has emerged as a leader in the speciality respiratory medicines, vaccines and HIV area. With a new wave of products to be launched, he highlights the importance of local authorities to reimburse new, innovative medicine and work for having more patients getting access to those. He also reflects on the impact the Swedish affiliate has on the global group, being an early launching pad for GSK products.
I am very proud of the Swedish affiliate, as we have a leadership position in most of our treatment areas, due to our strong performance in the last few years.
